Literature DB >> 35773392

Tirzepatide to treat obesity: phase III results.

Jordan Hindson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35773392     DOI： 10.1038/s41575-022-00657-z

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   73.082


× No keyword cloud information.
  1 in total

1.  Tirzepatide Once Weekly for the Treatment of Obesity.

Authors:  Ania M Jastreboff; Louis J Aronne; Nadia N Ahmad; Sean Wharton; Lisa Connery; Breno Alves; Arihiro Kiyosue; Shuyu Zhang; Bing Liu; Mathijs C Bunck; Adam Stefanski
Journal:  N Engl J Med       Date:  2022-06-04       Impact factor: 176.079
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.